Cefotaxime

Cefotaxime

SCHEMBL6017906

CON=C(C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1.Cl

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Cefotaxime. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 6/20 0.98
▸ MAPT P10636 3/20 0.98
▸ PPARG P37231 2/20 0.98
▸ SLC22A6 Q4U2R8 2/20 0.98
▸ SLC22A8 Q8TCC7 2/20 0.98
▸ SLC22A11 Q9NSA0 2/20 0.98
▸ ALB P02768 1/20 0.98
▸ HTR2C P28335 1/20 0.85
▸ TDP1 Q9NUW8 6/20 0.85
▸ APEX1 P27695 3/20 0.85
▸ ABCC4 O15439 2/20 0.85
▸ HSD17B10 Q99714 2/20 0.85
▸ LMNA P02545 2/20 0.85
▸ L3MBTL1 Q9Y468 2/20 0.85
▸ CYP1A2 P05177 1/20 0.85
▸ PKM P14618 1/20 0.85
▸ ALDH1A1 P00352 1/20 0.85
▸ POLB P06746 1/20 0.85
▸ RECQL P46063 1/20 0.85
▸ NPSR1 Q6W5P4 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefotaxime SCHEMBL9342532 1.00 NR1I2 (0.98) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL6017904 1.00 NR1I2 (0.98) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL28159824 1.00 NR1I2 (0.98) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL2220120 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL9395572 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL10748430 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL15410 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL14594281 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL3731937 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8
Cefotaxime SCHEMBL17422140 0.99 NR1I2 (1.00) NR1I2MAPTPPARGSLC22A6SLC22A8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108558908-B A kind of desalination method of ceftazidime mother liquor and the preparation method of cefotaxime 华北制药河北华民药业有限责任公司 2019-11-29 — — CN claimed
CN-109912625-A A kind of process reducing cefotaxime impurity H 辽宁美亚制药有限公司 2019-06-21 — — CN claimed
CN-109232611-A A kind of synthetic method of cefotaxime impurity H 上海上药新亚药业有限公司 2019-01-18 — — CN claimed
CN-108558908-A A kind of desalination method of ceftazidime mother liquor and the preparation method of cefotaxime 华北制药河北华民药业有限责任公司 2018-09-21 — — CN claimed
CN-107722040-A A kind of membrane separating method and device for recycling ceftazidime mother liquor 南京志坤环保科技有限公司 2018-02-23 — — CN claimed
CN-105646541-B A kind of former development quality cefotaxime and its pharmaceutical preparation 广东金城金素制药有限公司 2018-01-30 — — CN claimed
CN-106336418-A Solid phase synthesis method of ceftazidime hydrochloride 上海上药新亚药业有限公司 2017-01-18 — — CN claimed
CN-108383857-B Preparation method of cefmenoxime hydrochloride 山东四环药业股份有限公司 2021-02-05 — — CN disclosed
CN-108440570-B Preparation method of ceftiofur ester compound or halogen salt thereof 济宁市化工研究院 2020-12-04 — — CN disclosed
CN-108558908-B A kind of desalination method of ceftazidime mother liquor and the preparation method of cefotaxime 华北制药河北华民药业有限责任公司 2019-11-29 — — CN disclosed
CN-108558908-B A kind of desalination method of ceftazidime mother liquor and the preparation method of cefotaxime 华北制药河北华民药业有限责任公司 2019-11-29 — — CN disclosed
CN-109912625-A A kind of process reducing cefotaxime impurity H 辽宁美亚制药有限公司 2019-06-21 — — CN disclosed
CN-106336418-B A kind of solid-phase synthesis of cefotaxime hydrochloride 上海上药新亚药业有限公司 2019-02-01 — — CN disclosed
CN-100537768-C The preparation method of the plant that growth is improved under the nitrogen restricted condition AJINOMOTO KK (JP) 2009-09-09 — — CN disclosed
CN-1822763-A Method of constructing plant showing improved growtn under regulation of nitrogen AJINOMOTO KK (JP) 2006-08-23 — — CN disclosed
US-20060090219-A1 Methods for producing plants with improved growth under nitrogen-limited conditions AJINOMOTO CO., INC. (JP) 2006-04-27 — — US disclosed
EP-1647181-A1 METHOD OF CONSTRUCTING PLANT SHOWING IMPROVED GROWTN UNDER REGULATION OF NITROGEN Ajinomoto Co., Inc. (JP) 2006-04-19 — — EP disclosed
US-20050183168-A1 Plants having decreased dormancy period and methods producing the plants AJINOMOTO CO., INC. (JP) 2005-08-18 — — US disclosed
CN-1095670-C A package from for bicarbonate-containing powdery pharmaceutical compositions and a method of stabilizing the compositions OTSUKA PHARMA CO LTD (JP) 2002-12-11 — — CN disclosed
US-5359057-A Reacting 6-aminopenicillin derivative in the form of an acid addition salt with 2-benzothiazolyl thioester derivative to form amide of penecillin or cephalosporin derivatives; microbiocides HOFFMANN-LA ROCHE INC. (US) 1994-10-25 — — US disclosed
Send feedback